Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI

NCT07346131 is registered in ClinicalTrials.gov with Hôpital Fribourgeois as lead sponsor.

NCT NCT07346131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI
Lead sponsor
Hôpital Fribourgeois
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 7, 2026
Completion date
December 31, 2026
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast agent, medical imaging data, mri image enhancement